Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05920135
Status:
RECRUITING
Last Update Posted:
2024-01-16
First Post:
2023-05-26
Brief Title:
First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI
Sponsor:
Bridge Biotherapeutics Inc
Organization:
Bridge Biotherapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| EGFR Mutant Advanced Non-Small Cell Lung Cancer |
Keywords: